Resources

U.S. Centre for Disease Control (CDC): Lassa fever

Further information from the U.S. CDC in both English and French about the transmission, prevention, diagnosis and treatment of Lassa fever.

Read more

Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques

This resource describes the case-management of Lassa fever in a specific patient and the difficulties encountered in repatriating her for diagnosis and management, which is unavailable in Sierra Leone, are described.The experience with this case has implications for the medical care and safe handling of Lassa fever in both endemic and nonendemic areas.

Read more

Lassa fever: Epidemiology, clinical features, and social consequences

This resource describes the epidemiology of Lassa fever and its vector, as well as the clinical course and management of the disease. It then reports on current treatment efforts, surveillance and disease control before presenting community perspectives through a knowledge, attitude and practice survey and a qualitative study.  

Read more

Fever! The hunt for a new killer virus

This book explores the growth, history and current impact of the Lassa virus. It traces the pathway of the disease, from the first reported case to the current struggles of communities experiencing Lassa and notable points in its history. 

Read more

The coming plague: Newly emerging diseases in a world out of balance

This book explores the world's battles with microbes and examines the worldwide conditions that have culminated in recurrent outbreaks of newly discovered diseases, epidemics of diseases migrating to new areas, and mutated old diseases that are no longer curable.

Read more

Level 4 hunters of the CDC

This book explores how and why level 4 viruses, the highest degree of laboratory containment for isolation, are so deadly and how we can prevent further devastating epidemics from breaking out.

Read more

Lassa fever

In a study of Lassa fever in Sierra Leone, West Africa, this paper identifies two variables associated with a high risk of death, and evaluates the efficacy of ribavirin and Lassa virus–convalescent plasma for the treatment of Lassa fever.

Read more